Recent Biomarkers Research for November 2024
2022 Tumor Marker Testing Market Competitive Landscape: Shares by Country and Strategic Assessments of Leading Suppliers
Topics: Biomarkers
| Genomic Biomarkers Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
Topics: Genomics, Biomarkers, COVID-19/Coronavirus
| Genomic Biomarkers Market Share, Size, Trends, Industry Analysis Report, By Disease Indication (Oncology, Cardiovascular Diseases, Neurological Diseases, Renal Disorders, Others); By Validation; By Type; By End-Use; By Region; Segment Forecast, 2021 - 202
Topics: Genomics, Biomarkers, Hematology & Oncology, Cardiovascular, Oncology/Hematology, Renal
| The Global Market for Biomarkers, 2015-2020 (Cancer Markers, Cardiac Markers, Immunological Disease Markers, Infectious Disease Markers, Others)
Topics: Biomarkers
Regions: Global
| Global Digital Biomarkers Market - A Global and Regional Analysis: Focus on System Component, Type, Application, End User, Regional and Country-Wise Analysis - Analysis and Forecast, 2022-2028
Topics: Biomarkers
Regions: Global
| Liquid Biopsy Market Size By Biomarkers (Circulating Tumor Cells [CTC], Circulating Tumor DNA [ctDNA]), By Product (Kits & Reagents, Assay & Panels), By Application (Lung Cancer, Breast Cancer, Colorectal cancer, Prostate Cancer), COVID-19 Impact Analysis
Topics: Molecular Biology, Biomarkers, Cancer Treatment, COVID-19/Coronavirus, Minimally Invasive Surgery, Oncology/Hematology, Men's Health
Regions: Global
| 2022-2026 Philippines Tumor Markers Testing Market High-Growth Opportunities for Cancer Diagnostic Tests and AnalyzersSupplier Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunit
Topics: Biomarkers, Cancer Treatment, Hematology & Oncology
Regions: Philippines
| 2022-2026 Poland Tumor Markers Testing Market High-Growth Opportunities for Cancer Diagnostic Tests and AnalyzersSupplier Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities f
Topics: Instrumentation & Equipment, Biomarkers, Cancer Treatment, Hematology & Oncology, Oncology/Hematology
Regions: Poland
| 2022-2026 Canada Tumor Markers Testing Market High-Growth Opportunities for Cancer Diagnostic Tests and AnalyzersSupplier Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities f
Topics: Biomarkers, Cancer Treatment, Hematology & Oncology
Regions: Canada
| 2022-2026 Ecuador Tumor Markers Testing Market High-Growth Opportunities for Cancer Diagnostic Tests and AnalyzersSupplier Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities
Topics: Instrumentation & Equipment, Biomarkers, Cancer Treatment, Hematology & Oncology
Regions: Ecuador
| 2022-2026 Egypt Tumor Markers Testing Market High-Growth Opportunities for Cancer Diagnostic Tests and AnalyzersSupplier Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities fo
Topics: Instrumentation & Equipment, Biomarkers, Cancer Treatment, Hematology & Oncology
Regions: Egypt
| 2022-2026 New Zealand Tumor Markers Testing Market High-Growth Opportunities for Cancer Diagnostic Tests and AnalyzersSupplier Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunit
Topics: Instrumentation & Equipment, Biomarkers, Cancer Treatment, Hematology & Oncology
Regions: New Zealand
| Global Rare Biomarkers Specimen Collection & Stabilization Market (2020-2025) by Product, Type, Application, End user and Geography, IGR Competitive Analysis, Impact of Covid-19, Ansoff Analysis
Topics: Biomarkers, COVID-19/Coronavirus
Regions: Global
| Global Biomarkers Market (2021-2026) by Type, Disease Indication, Application, Components, End User, and Geography, IGR Competitive Analysis, Impact of Covid-19, Ansoff Analysis
Topics: Biomarkers, COVID-19/Coronavirus
Regions: Global
| Global Cardiac Biomarker Market (2021-2026) by Product, Type, Location of Testing, Application, and Geography, IGR Competitive Analysis, Impact of Covid-19, Ansoff Analysis
Topics: Biomarkers, COVID-19/Coronavirus, Cardiovascular
Regions: Global
| Global Brain Biomarkers Market (2021-2026) by Product, Indication, Application, End User, and Geography, IGR Competitive Analysis, Impact of Covid-19, Ansoff Analysis
Topics: Biomarkers, COVID-19/Coronavirus, CNS/Neurology
Regions: Global
| 2022-2026 China Cancer Diagnostics Market Opportunities for Major Tumor Markers - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
Topics: Instrumentation & Equipment, Biomarkers, Cancer Treatment, Hematology & Oncology, Oncology/Hematology
Regions: China
| 2022-2026 Germany Cancer Diagnostics Market Opportunities for Major Tumor Markers - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
Topics: Instrumentation & Equipment, Biomarkers, Cancer Treatment, Hematology & Oncology, Oncology/Hematology
Regions: Germany
| Global Renal Biomarkers Market - 2021-2028
Topics: Biomarkers, Renal
Regions: Global
| Global Patient Derived Xenograft (PDX) Models Market - 2021-2028
Topics: Biomarkers, Personalized Medicine, Cancer Treatment
Regions: Global
| Patient Derived Xenograft/PDX Model Market Report: Trends, Forecast and Competitive Analysis
Topics: Research & Development, Biomarkers, Cancer Treatment
| Oncology Based In-vivo CRO Market Size, Share & Trends Analysis Report By Indication (Blood Cancer, Solid Tumor), By Model (Syngeneic Model, Patient Derived Xenograft (PDX), Xenograft), By Region, And Segment Forecasts, 2021 - 2028
Topics: Biomarkers, Personalized Medicine, Cancer Treatment, Hematology & Oncology, Oncology/Hematology
| miRNA Research and Diagnostics Markets: Forecast to 2019
Topics: Antisense & RNAi Technology, Biomarkers
| Metabolomics Global Market Report 2022
Including: 1) By Product & Service: Metabolomics Instruments; Metabolomics Bioinformatics Tools & Services
2) By Application: Biomarker Discovery; Drug Discovery; Toxicology Testing; Nutrigenomics; Functional Genomi
Topics: Genomics, Informatics, Drug Development, Biomarkers, Personalized Medicine, Cancer Treatment, Drug Discovery, Oncology/Hematology
Regions: Global
| Liquid Biopsy Market Size, Share & Trends Analysis Report By Biomarker (Exosomes, CTC), By Technology (NGS, PCR Microarrays), By Sample Type, By Region (APAC, North America), And Segment Forecasts, 2021 - 2028
Topics: Molecular Biology, Biomarkers, Microarray , Minimally Invasive Surgery
Regions: Asia, North America
| Cardiac Biomarkers Market, by Product Type (Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Troponins (T and I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Ischemia-modified Albumin (IMA), and Others), by Application (Myocardial Infarction, Cong
Topics: Enzymes, Biomarkers, Point-of-Care, Lab Testing Services, Cardiovascular
Regions: Africa, Europe, Middle East, North America, Oceania, South America
| Cardiac Biomarkers Testing Devices - Market Insights, Competitive Landscape and Market Forecast-2026
Topics: Biomarkers, Cardiovascular
| 2022-2026 Europe Cancer Diagnostics Market Opportunities for Major Tumor Markers for Major Tumor Markers: A 38-Country Analysis - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipelin
Topics: Instrumentation & Equipment, Biomarkers, Cancer Treatment, Hematology & Oncology, Oncology/Hematology
Regions: Europe
| 2022-2026 Middle East Cancer Diagnostics Market Opportunities for Major Tumor Markers: An 11-Country Analysis - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opport
Topics: Instrumentation & Equipment, Biomarkers, Cancer Treatment, Hematology & Oncology, Oncology/Hematology
Regions: Middle East
| 2022-2026 North America Cancer Diagnostics Market Opportunities for Major Tumor Markers: US, Canada, Mexico - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportun
Topics: Instrumentation & Equipment, Biomarkers, Cancer Treatment, Hematology & Oncology, Oncology/Hematology
Regions: Canada, United States, Mexico, North America
| Liquid Biopsy Market Report: Trends, Forecast and Competitive Analysis
Topics: Molecular Biology, Biomarkers, Cancer Treatment, Minimally Invasive Surgery
| Global Non-Invasive Liquid Biopsy Market: Focus on Offering, Sample, Application, Technology, End Users, Country Data (16 Countries), and Competitive Landscape - Analysis and Forecast, 2021-2031
Topics: Molecular Biology, Biomarkers, Minimally Invasive Surgery
Regions: Global
| Liquid Biopsy in Cancer Diagnostics - Market Insights, Competitive Landscape and Market Forecast-2026
Topics: Molecular Biology, Biomarkers, Cancer Treatment, Hematology & Oncology, Minimally Invasive Surgery, Oncology/Hematology
| Liquid Biopsy for Cancer Diagnostics – Competitive Landscape and Pipeline Analysis, 2022
Topics: Biomarkers, Cancer Treatment, Hematology & Oncology, Minimally Invasive Surgery, Drug Discovery, Oncology/Hematology
| Global Genomic Medicine Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2016-2026
Topics: Genomics, Biomarkers
Regions: Global
| 2022-2026 Europe Cancer Diagnostics Market Opportunities for Major Tumor Markers: France, Germany, Italy, Spain, UK - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging
Topics: Biomarkers, Hematology & Oncology
Regions: France, Germany, Italy, Spain, United Kingdom, Europe
| Precision Medicine Market Size By Product Type (Diagnostics {Genetic Tests, Biomarker Based Tests}, Therapeutics), By Application (Oncology, CNS, Immunology, Respiratory), By End-use (Hospitals, Diagnostic Centers, Research & Academic Institutes), COVID-1
Topics: Molecular Biology, Biomarkers, Personalized Medicine, COVID-19/Coronavirus, Hospitals & Clinics
Regions: Global
| Genomic Biomarker Market, by Indication (Oncology, Cardiovascular diseases, Neurological diseases, and Others), by End User (Hospitals, Diagnostic & Research Laboratories, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Mid
Topics: Genomics, Biomarkers, Hospitals & Clinics, Laboratories
Regions: Africa, Asia, Europe, Middle East, North America, Oceania, South America
| Global Cancer Biomarkers Market, 2021-2027
Topics: Biomarkers, Cancer Treatment, Oncology/Hematology
Regions: Global
| Biomarkers Market Size, Share & Trends Analysis Report By Type (Safety, Efficacy), By Application (Diagnostic, Drug Discovery & Development), By Disease (CVD, Cancer), By Region, And Segment Forecasts, 2021 - 2028
Topics: Drug Development, Biomarkers, Cancer Treatment, Drug Discovery, Oncology/Hematology
| 2021-2025 UK Hospital Cancer Diagnostics Market: Supplier Shares by Test, Volume and Sales Segment Forecasts for Major Tumor Markers, Competitive Landscape, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
Topics: Biomarkers, Cancer Treatment, Hospitals & Clinics, Hematology & Oncology
Regions: United Kingdom
| In-Vitro Colorectal Cancer Screening Tests Market Size By Test Type (Fecal Occult Blood Tests {Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test, Immuno-FOB ELISA Test}, Biomarker Tests {Tumor M2-PK Stool Test, Transferrin
Topics: Biomarkers, Cancer Treatment, COVID-19/Coronavirus, Hospitals & Clinics, Laboratories, Immunoassays, Oncology/Hematology
| Physician Office Laboratory (POL) Markets, 3rd Edition (Markets for Office-Based Chemistry, Glucose, Coagulation PT, Autoimmune, HIV, Hep, Cardiac Markers, PSA, Flu, HbA1c, Hematology, FOB and Other Tests)
Topics: Biomarkers, Physicians' Offices, Immunoassays, Molecular Assays, Point-of-Care
| Companion Diagnostics in the COVID-19 Era: Market Analysis and Opportunities
Topics: Biomarkers, Personalized Medicine, Next Generation Sequencing, COVID-19/Coronavirus, Companion Diagnostics, Cardiovascular, Infectious Diseases, Respiratory/Pulmonary, Oncology/Hematology
| 2021-2025 Global Cancer Diagnostics Market: Unmet Needs, Supplier Shares and Strategies, Segment Volume and Sales Forecasts for Major Tumor Markers, Emerging Technologies and Trends, Instrumentation Pipeline, Growth Opportunities
Topics: Biomarkers, Cancer Treatment, Hematology & Oncology
Regions: Global
| 2021-2025 Asia-Pacific Cancer Diagnostics Market Outlook: A 17-Country Analysis - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for Major Tumor Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunitie
Topics: Biomarkers, Cancer Treatment, Hematology & Oncology
Regions: Asia, Oceania
| 2021-2025 Europe Cancer Diagnostics Market Outlook: A 38-Country Analysis - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for Major Tumor Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for
Topics: Biomarkers, Cancer Treatment, Hematology & Oncology
Regions: Europe
| 2021-2025 Latin America Cancer Diagnostics Market Outlook: A 22-Country Analysis - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for Major Tumor Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportuniti
Topics: Biomarkers, Cancer Treatment, Hematology & Oncology
Regions: South America
| 2021-2025 Global Cancer Diagnostics Market Outlook: USA, Europe, Japan - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for Major Tumor Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Sup
Topics: Biomarkers, Cancer Treatment, Hematology & Oncology
Regions: Japan, United States, Europe, Global
| 2021-2025 Europe Cancer Diagnostics Market Outlook: France, Germany, Italy, Spain, UK - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for Major Tumor Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opport
Topics: Biomarkers, Cancer Treatment, Hematology & Oncology
Regions: France, Germany, Italy, Spain, United Kingdom, Europe
|
Prev | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | Next
About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports, company profiles and country profiles from over 350 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.
|
